Really wonder how their public benefit mission will align with the expectations to maximize shareholder returns
I want to be optimistic, but I just can’t imagine the public benefit mission winning out in the market
> the expectations to maximize shareholder returns
There is no legal requirement to do so. So they can simply set the expectation upfront that they won't do it.
They can co-exist, maybe only if times are good I suppose. It's not too different from Apple here:
https://www.theguardian.com/environment/2014/mar/03/tim-cook...
The PBC mission is directly aligned. The "public" that they benefit are defined as their shareholders.
They’re not the first PBC to go public. Coursera, Warby Parker, and United Therapeutics (not affiliated with UHC) have all followed the same path. Not sure if we’ve had enough time to see this tension play out, public benefit corps are only a decade and a half old and most of these companies IPOd in 2020-2021, but there’s probably some evidence one way or the other